Anti-ANK2/ ANK-2/ LQT4 monoclonal antibody

Anti-ANK2/ ANK-2/ LQT4 antibody for FACS & in-vivo assay

Target products collectionGo to ANK2/ANK2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1988-Ab-1/ GM-Tg-hg-MP1988-Ab-2Anti-Human ANK2 monoclonal antibodyHuman
GM-Tg-rg-MP1988-Ab-1/ GM-Tg-rg-MP1988-Ab-2Anti-Rat ANK2 monoclonal antibodyRat
GM-Tg-mg-MP1988-Ab-1/ GM-Tg-mg-MP1988-Ab-2Anti-Mouse ANK2 monoclonal antibodyMouse
GM-Tg-cynog-MP1988-Ab-1/ GM-Tg-cynog-MP1988-Ab-2Anti-Cynomolgus/ Rhesus macaque ANK2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1988-Ab-1/ GM-Tg-felg-MP1988-Ab-2Anti-Feline ANK2 monoclonal antibodyFeline
GM-Tg-cang-MP1988-Ab-1/ GM-Tg-cang-MP1988-Ab-2Anti-Canine ANK2 monoclonal antibodyCanine
GM-Tg-bovg-MP1988-Ab-1/ GM-Tg-bovg-MP1988-Ab-2Anti-Bovine ANK2 monoclonal antibodyBovine
GM-Tg-equg-MP1988-Ab-1/ GM-Tg-equg-MP1988-Ab-2Anti-Equine ANK2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1988-Ab-1/ GM-Tg-hg-MP1988-Ab-2; GM-Tg-rg-MP1988-Ab-1/ GM-Tg-rg-MP1988-Ab-2;
GM-Tg-mg-MP1988-Ab-1/ GM-Tg-mg-MP1988-Ab-2; GM-Tg-cynog-MP1988-Ab-1/ GM-Tg-cynog-MP1988-Ab-2;
GM-Tg-felg-MP1988-Ab-1/ GM-Tg-felg-MP1988-Ab-2; GM-Tg-cang-MP1988-Ab-1/ GM-Tg-cang-MP1988-Ab-2;
GM-Tg-bovg-MP1988-Ab-1/ GM-Tg-bovg-MP1988-Ab-2; GM-Tg-equg-MP1988-Ab-1/ GM-Tg-equg-MP1988-Ab-2
Products NameAnti-ANK2 monoclonal antibody
Formatmab
Target NameANK2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ANK2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ANK2/ ANK-2/ LQT4 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1988
    Target NameANK2
    Gene ID287,109676,362036,702180,487908,101100129,539238,100064198
    Gene Symbol and Synonyms100043364,ANK-2,ANK2,Ank3,ANKB,brank-2,CFAP87,FAP87,Gm4392,LQT4
    Uniprot AccessionQ01484
    Uniprot Entry NameANK2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000145362
    Target ClassificationN/A

    The target: ANK2, gene name: ANK2, also named as ANK-2, LQT4, brank-2. This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Ankyrins play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. The protein encoded by this gene is required for targeting and stability of Na/Ca exchanger 1 in cardiomyocytes. Mutations in this gene cause long QT syndrome 4 and cardiac arrhythmia syndrome. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.